The decay phase of Ca2+ transients in skeletal muscle: regulation and physiologyThis paper is one of a selection of papers published in this Special Issue, entitled 14th International Biochemistry of Exercise Conference – Muscles as Molecular and Metabolic Machines, and has undergone the Journal’s usual peer review process.
- 1 June 2009
- journal article
- review article
- Published by Canadian Science Publishing in Applied Physiology, Nutrition, and Metabolism
- Vol. 34 (3) , 373-376
Abstract
Cytosolic Ca2+ transients associated with contraction and relaxation cycles in skeletal muscle are primarily dependent on the kinetics of Ca2+ release and Ca2+ uptake by the sarcoplasmic reticulum (SR). In humans, sarco(endo)plasmic reticulum Ca2+-ATPases (SERCAs) are solely responsible for the removal of Ca2+ from the cytosol following muscle contraction. There are several signalling systems involved in the acute regulation of SERCAs required to achieve a given Ca2+ transient during muscle contraction–relaxation cycles. Cyclic-AMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase signalling activate SERCAs through the regulation of the endogenous SERCA-regulatory proteins, phospholamban and sarcolipin, both of which are highly expressed in human skeletal muscle. Recent studies on the regulation of SERCA2b in arterial smooth muscle and work from my laboratory on the interaction between SERCAs and the inducible 70-kDa heat shock protein suggests a novel role for redox signalling in regulating SERCA activity. In the absence of fatigue, activation of these signalling systems in response to repeated muscle activity serves to increase the rate of cytosolic free Ca2+ ([Ca2+]f) decay (i.e., SR Ca2+ uptake) and the speed of muscle relaxation.Keywords
This publication has 36 references indexed in Scilit:
- Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractilityProceedings of the National Academy of Sciences, 2007
- Differential expression of sarcolipin protein during muscle development and cardiac pathophysiologyJournal of Molecular and Cellular Cardiology, 2007
- Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylationProceedings of the National Academy of Sciences, 2006
- Targeted Overexpression of Sarcolipin in the Mouse Heart Decreases Sarcoplasmic Reticulum Calcium Transport and Cardiac ContractilityJournal of Biological Chemistry, 2006
- S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxideNature Medicine, 2004
- Sarcolipin regulates sarco(endo)plasmic reticulum Ca 2+ -ATPase (SERCA) by binding to transmembrane helices alone or in association with phospholambanProceedings of the National Academy of Sciences, 2003
- Effects of oxidation and reduction on contractile function in skeletal muscle fibres of the ratThe Journal of Physiology, 2003
- Sarcolipin Inhibits Polymerization of Phospholamban to Induce Superinhibition of Sarco(endo)plasmic Reticulum Ca2+-ATPases (SERCAs)Journal of Biological Chemistry, 2002
- Human α and β parvalbuminsEuropean Journal of Biochemistry, 1993
- Control of muscle contractionQuarterly Reviews of Biophysics, 1969